Table 2.
Incidence of long-term renal outcomes after the diagnosis of persistent microalbuminuria among 325 participants in the DCCT/EDIC Study
Follow-up | Events | |||||||
---|---|---|---|---|---|---|---|---|
Median (years) | Range (years) | Person-years | N | Incidence rate* | Cumulative incidence | |||
5 years | 10 years | 15 years | ||||||
Overall follow-up | 13 | 1 – 23 | 4096 | - | - | - | - | - |
Normoalbuminuria | 8 | 2 – 21 | 1302 | 117 | 9.1 | 23% | 40% | 48% |
Macroalbuminuria | 8 | 0 – 21 | 2578 | 98 | 3.8 | 22% | 28% | 39% |
Impaired GFR | 11 | 0 – 22 | 3416 | 60 | 1.8 | 10% | 15% | 19% |
ESRD | 12 | 1 – 23 | 4026 | 21 | 0.5 | 1% | 4% | 7% |
per 100 person-years. GFR = glomerular filtration rate; ESRD = end-stage renal disease.